ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 124

Reliability of an Ultrasound Scoring Measure for Juvenile Localized Scleroderma (jLS)

Suzanne C. Li1, Melissa S. Liebling2, Andrea S. Doria3, Molly Dempsey-Robertson4, Carsten Hamer5, Sven Opitz5, Faridali Ramji6, Stephanie Edgerton6, Jose Jarrin3, Tanicka Kornyat2, Michael Malone6, Arun Mohanta3, Shuzhen Zhang4 and Knut M. Wittkowski7, 1Pediatrics, Joseph M Sanzari Children's Hospital, Hackensack University Medical Center, Hackensack, NJ, 2Radiology, Hackensack University Medical Center, Hackensack, NJ, 3Diagnostic Imaging, Hospital for Sick Children, Toronto, ON, Canada, 4Radiology, Texas Scottish Rite Hospital, Dallas, TX, 5Radiology, Schon Klinik Hamburg Eilbek, Hamburg, Germany, 6Radiology, University of OK Health Science Center, Okc, OK, 7Center for Clinical and Translational Science, Rockefeller University, New York, NY

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Activity score, Pediatric rheumatology, scleroderma and ultrasound

  • Tweet
  • Email
  • Print
Session Information

Title: Imaging of Rheumatic Diseases: Ultrasound, Nuclear Medicine and Fluorescence Imaging

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Although ultrasound (US) shows great potential for aiding assessment of LS disease activity, its use has been limited because both image acquisition and interpretation are operator dependent. Our multi- disciplinary group (LOCUS, LOcalized scleroderma Clinical and Ultrasound Study group) has worked to develop an US scoring measure (U-DA) to help standardize sonographic interpretation of jLS patients (Pediatr Rheumatol 2010;8:14). The U-DA evaluates echogenicity and vascularity (color Doppler signal) differences in each tissue layer of the lesion compared with the corresponding normal tissue layer. A score of 0 represents no difference n the lesion compared with the normal site. 

Objective: To assess the reliability of an ultrasound scoring measure (U-DA) for jLS.

Methods:

LOCUS conducted a 3-day workshop meeting in 2009 on acquiring and interpreting US scans from jLS patients, which was attended by 12 radiologists and sonographers from 5 pediatric rheumatology centers. The group had developed a preliminary ultrasound scoring measure in 2007, and this preliminary measure was reviewed in conjunction with jLS US images showing the range of sonographic differences that had been observed up to the time of the meeting. This review led to modification of U-DA; definitions for scoring levels were then finalized. A tutorial on U-DA scoring was conducted, followed by individual scoring of two jLS US scans and collective review of scoring of these scans. Eleven attendees then scored a randomly-ordered set of 16 jLS scans, with 10 attendees rescoring the same set in a different random order on a second day. Kendall coefficients of concordance were calculated to determine intra-and inter-rater reliability, and scoring of each U-DA was separately analyzed to evaluate for potential issues. 

Results:

Raters showed moderate to high intra-rater reliability for scoring total echogenicity (Kendall’s coefficient 0.77 to 0.92) and vascularity (Kendall’s coefficient 0.64-0.92), where total refers to sum of scores from each identifiable tissue layer (dermis, hypodermis, deep tissue). A moderate level of inter-rater reliability was found for scoring total echogenicity (Kendall’s coefficient 0.64, 0.56) and vascularity (0.58, 0.57).  A high level of agreement was observed for dermis scoring (for example, majority of raters agreed on dermis vascularity score for 15/16 scans), with a much lower level of agreement observed for deep tissue scoring (majority agreement for 10/16 scans on deep tissue vascularity score). 

Table 1: Intra- and Inter-rater reliability of U-DA Total Echogenicity, Total Vascularity

U-DA Scoring Parameter

Kendall’s Coefficient

P value

Total Echo: Inter-rater, 1st reading

0.64

<0.0001

Total Echo: Inter-rater, 2nd reading

0.56

<0.0001

Total Echo: Intra-rater reliability range

0.77-0.92

0.118 to <0.0001

Total Vasc: Inter-rater, 1st reading

0.58

<0.0001

Total Vasc: Inter-rater, 2nd reading

0.57

<0.0001

Total Vasc: Intra-rater reliability range

0.64-0.92

0.1374 to <0.0001

Conclusion:   The U-DA was found to have a moderate level of intra- and inter-rater reliability for total echogenicity and vascularity. Among the different tissue layers, deep tissue layer showed the lowest concordance. More training in deep tissue layer evaluation may further improve the reliability of scoring the U-DA.


Disclosure:

S. C. Li,
None;

M. S. Liebling,
None;

A. S. Doria,
None;

M. Dempsey-Robertson,
None;

C. Hamer,
None;

S. Opitz,
None;

F. Ramji,
None;

S. Edgerton,
None;

J. Jarrin,
None;

T. Kornyat,
None;

M. Malone,
None;

A. Mohanta,
None;

S. Zhang,
None;

K. M. Wittkowski,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reliability-of-an-ultrasound-scoring-measure-for-juvenile-localized-scleroderma-jls/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology